醫師調查：腫瘤科醫師認為人工智慧將塑造癌症治療的未來

人工智慧可以比人類更快、更準確地分析醫學影像，加速檢測和診斷，幫助推進癌症治療。此外，由於準確度更高，人工智慧可以最大限度地減少誤診。透過分析基因組資料，人工智慧可以預測治療結果，幫助實現癌症治療的個人化。

透過持續提升模式辨識能力，深度學習可以更準確地區分惡性腫瘤和良性腫瘤，進一步增強癌症檢測。

本報告調查了美國和五個歐洲國家（法國、德國、義大利、西班牙和英國）的192名腫瘤醫學專家，以評估人工智慧演算法在癌症診斷和治療計劃中的應用程度（目前和未來）。

報告內容

• 人工智慧在影像分析中的應用可以改善各種類型癌症的檢測和分類。目前，人工智慧軟體在多大程度上用於解讀癌症診斷影像？
• 在多大程度上同意五年後，利用人工智慧影像分析診斷患者癌症的速度將顯著提高？
• 深度學習人工智慧可以預測疾病進展。在規劃患者的治療方案時，目前在多大程度上使用深度學習 AI 來估計患者特定的風險因素？
• AI演算法也可以應用於基因組測試，以識別對抗癌藥物的遺傳易感性。目前在多大程度上使用基於人工智慧的臨床決策支援工具為患者制定個人化的治療方案？
• 在多大程度上同意人工智慧將在未來五年內徹底改變病患照護計畫？

The backstory

Helping to advance cancer treatment, AI speeds up detection and diagnosis by analysing medical images faster and with more precision than can be done by humans. In addition, its greater accuracy allows AI to minimise false-positive diagnoses. Through the analysis of genomic data, AI helps personalise oncology care by predicting treatment response.

Deep learning further enhances cancer detection by continuously improving its pattern recognition capabilities, which allows it to more precisely distinguish malignant tumours from benign ones.

The physician view

FirstWord polled 192 oncologists based in the US and EUR5 (France, Germany, Italy, Spain and the UK) to assess current and future adoption levels of AI algorithms in cancer diagnosis and treatment planning.

Key Questions Answered:

• 1. AI can be applied to image analysis to improve detection and classification of different types of cancer. How often do you currently use AI software to help with interpreting images for cancer diagnosis?
• 2. Thinking ahead, how much do you agree that AI-based image analysis will significantly improve the speed of cancer diagnosis for your patients in five years' time?
• 3. Deep learning AI can predict disease progression. To what extent are you currently utilising deep learning AI to estimate patient-specific risk factors when planning treatment programmes for your patients?
• 4. AI algorithms can also be applied to genomic testing to identify genetic anticancer drug susceptibility. To what extent are you currently using AI-based clinical decision support tools to develop personalised treatment plans for your patients?
• 5. To what extent do you agree that AI will revolutionise treatment planning for your patients over the next five years?

Methodology

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.